Both insulin and LONG R 3 IGF-I, a more potent supplement that directly targets and activates the IGF-I receptor, are employed by the biopharmaceutical industry today to support the growth of recombinant cell lines
Tier 2: Telemedicine clinics ($199-$425 per month)
In animals, FGF21 causes weight loss and improved insulin sensitivity without hypoglycemia
We have unimolecular, dual agonist, tri-agonist, [and] tetra-agonists, where you can just add an alkyl group, and then you can tune GLP-1 receptor [sensitivity] up or down, says Kumar
Most people want to avoid surgery, which they should because it has a higher risk and more complications
Mobile barrier mechanisms for Na+-coupled symport in an MFS sugar transporter